Renalytix plc - Ordinary shares, nominal value 0.0025 per share

Q: What does CUSIP G7489R108 represent in this 13F holders report?

CUSIP G7489R108 is the security identifier for G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share used to aggregate holder disclosures.

Q: How many institutions held G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share in Q1 2020?

3 institutional investors reported G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: G7489R108

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Ordinary shares, nominal value 0.0025 per share
Shares outstanding: 328,915,843
Total 13F shares: 526,573
Share change: +62,817
Total reported value: $1,482,000
Price per share: $2.73
Number of holders: 3
Value change: +$167,772
Number of buys: 1
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP G7489R108?
CUSIP G7489R108 identifies G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP G7489R108:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

Top shareholders of G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GOFEN & GLOSSBERG LLC /IL/	13F	Company	0.06%	183,100	$795,000	—	31 Dec 2019	13F
TIAA, FSB	13F	Company	0.05%	161,019	$776,000	—	31 Dec 2019	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.04%	119,637	$577,000	—	31 Dec 2019	13F

Institutional Holders of Renalytix plc - Ordinary shares, nominal value 0.0025 per share as of Q1 2020

As of 31 Mar 2020, Renalytix plc - Ordinary shares, nominal value 0.0025 per share was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 526,573 shares. The largest 3 holders included GILDER GAGNON HOWE & CO LLC, GOFEN & GLOSSBERG LLC /IL/, and TIAA, FSB. This page lists 3 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.